ArticleCureus2019
Impact of High Body Weight on Mortality in Critically Ill Patients Receiving Meropenem for Pneumonia.
Article in Cureus, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBody size has a significant impact on pharmacokinetics of antibiotics, and leaving body size out of consideration may increase the probability of therapeutic failure. The objective of this study is to evaluate the impact of high body weight on mortality in critically ill patients who received meropenem for pneumonia.
methodsThe electronic medical records of a respiratory intensive care unit (RICU) were retrospectively screened for patients with the first diagnosis of pneumonia and receiving meropenem from 2014 to 2018. Clinical variables and outcome measures were collected in patients who met inclusion criteria. Patients were assigned to quartiles based on body weight (quartile (Q) 1 <52.25 kg; Q2 52.25-65.00 kg; Q3 65.01-72.85; Q4 >72.85 kg). Logistic regression analyses were used to investigate associations between the body weight and mortality. Mortality rates were compared among different body weight quartiles.
resultsOf 1,621 patients admitted to the RICU, 146 patients met the inclusion criteria. There was no significant difference in mortality of patients in different body weight quartiles. In subgroup analysis of patients receiving mechanical ventilation, there was an association between body weight and RICU mortality (odds ratio, 2.97 [1.128-7.846]; P=0.027). In Q4, mortality rate of patients who received meropenem 2 g/day was significantly higher than that of patients who received 3 g/day (69.56% vs 35.71%; P=0.047).
conclusionsThere was an association between body weight and mortality in patients receiving mechanical ventilation. Compared with low-dose meropenem, high-dose meropenem might decrease mortality rate of critically ill patients with highest body weight.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.